111 related articles for article (PubMed ID: 29016132)
1. Toward Understanding Mcl-1 Promiscuous and Specific Binding Mode.
Fogha J; Marekha B; De Giorgi M; Voisin-Chiret AS; Rault S; Bureau R; Sopkova-de Oliveira Santos J
J Chem Inf Model; 2017 Nov; 57(11):2885-2895. PubMed ID: 29016132
[TBL] [Abstract][Full Text] [Related]
2. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics study of segment peptides of Bax, Bim, and Mcl-1 BH3 domain of the apoptosis-regulating proteins bound to the anti-apoptotic Mcl-1 protein.
Zhao RN; Fan S; Han JG; Liu G
J Biomol Struct Dyn; 2015; 33(5):1067-81. PubMed ID: 24865469
[TBL] [Abstract][Full Text] [Related]
4. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.
Day CL; Smits C; Fan FC; Lee EF; Fairlie WD; Hinds MG
J Mol Biol; 2008 Jul; 380(5):958-71. PubMed ID: 18589438
[TBL] [Abstract][Full Text] [Related]
5. Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-X
Reddy CN; Manzar N; Ateeq B; Sankararamakrishnan R
Biochemistry; 2020 Nov; 59(45):4379-4394. PubMed ID: 33146015
[TBL] [Abstract][Full Text] [Related]
6. Modeling the Binding of Anticancer Peptides and Mcl-1.
Alhammadi SHA; Baby B; Antony P; Jobe A; Humaid RSM; Alhammadi FJA; Vijayan R
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928234
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.
Hedir S; De Giorgi M; Fogha J; De Pascale M; Weiswald LB; Brotin E; Marekha B; Denoyelle C; Denis C; Suzanne P; Gautier F; Juin P; Ligat L; Lopez F; Carlier L; Legay R; Bureau R; Rault S; Poulain L; Oliveira Santos JS; Voisin-Chiret AS
Eur J Med Chem; 2018 Nov; 159():357-380. PubMed ID: 30308410
[TBL] [Abstract][Full Text] [Related]
8. Structural Mechanism for Regulation of Bcl-2 protein Noxa by phosphorylation.
Karim CB; Espinoza-Fonseca LM; James ZM; Hanse EA; Gaynes JS; Thomas DD; Kelekar A
Sci Rep; 2015 Sep; 5():14557. PubMed ID: 26411306
[TBL] [Abstract][Full Text] [Related]
9. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.
Dutta S; Gullá S; Chen TS; Fire E; Grant RA; Keating AE
J Mol Biol; 2010 May; 398(5):747-62. PubMed ID: 20363230
[TBL] [Abstract][Full Text] [Related]
10. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
11. Mouse Noxa uses only the C-terminal BH3-domain to inactivate Mcl-1.
Weber A; Ausländer D; Häcker G
Apoptosis; 2013 Sep; 18(9):1093-105. PubMed ID: 23733106
[TBL] [Abstract][Full Text] [Related]
12. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands.
Day CL; Chen L; Richardson SJ; Harrison PJ; Huang DC; Hinds MG
J Biol Chem; 2005 Feb; 280(6):4738-44. PubMed ID: 15550399
[TBL] [Abstract][Full Text] [Related]
14. Allosteric inhibition of antiapoptotic MCL-1.
Lee S; Wales TE; Escudero S; Cohen DT; Luccarelli J; Gallagher CG; Cohen NA; Huhn AJ; Bird GH; Engen JR; Walensky LD
Nat Struct Mol Biol; 2016 Jun; 23(6):600-7. PubMed ID: 27159560
[TBL] [Abstract][Full Text] [Related]
15. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
16. Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study.
Chen Y; Wang J; Zhang J; Wang W
J Biomol Struct Dyn; 2018 Nov; 36(15):3967-3977. PubMed ID: 29137527
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the degradation of Mcl-1 induced by BH3 domains.
Czabotar PE; Lee EF; van Delft MF; Day CL; Smith BJ; Huang DC; Fairlie WD; Hinds MG; Colman PM
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6217-22. PubMed ID: 17389404
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
[TBL] [Abstract][Full Text] [Related]
19. Binding mode of Pyridoclax to myeloid cell leukemia-1 (Mcl-1) revealed by nuclear magnetic resonance spectroscopy, docking and molecular dynamics approaches.
Bourafai-Aziez A; Sebban M; Benabderrahmane M; Marekha B; Denis C; Paysant H; Weiswald LB; Carlier L; Bureau R; Coadou G; Ravault D; Voisin-Chiret AS; Sopková-de Oliveira Santos J; Oulyadi H
J Biomol Struct Dyn; 2020 Sep; 38(14):4162-4178. PubMed ID: 31612791
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
